Sudden fatigue, joint pain, sexual dysfunction: hereditary hemochromatosis harms, sooner and later
 |
| New research is showing how badly HH impacts quality of life |
Hereditary haemochromatosis (HH) is one of the most common genetic conditions in people of Northern European ancestry, yet many have never heard of it. In the late 1990s my wife started suffering the effects of HH but was not diagnosed until 2008. Ever since then I have tried to raise awareness of this condition whenever I can.
Unfortunately, in the decade and a half since I created this website (July, 2010), researchers have found that HH may have a greater impact on the health of those who have it than was once thought. This article provides an update on the shifting assessment of HH and shares even more reasons for us all to learn about this potentially disabling and sometimes deadly condition.
People with HH inherited certain mutations of a gene called HFE that may absorb more iron than they need. Over time, this "iron overload" can build up in organs such as the liver, pancreas, heart, and joints, resulting in the issues and symptoms listed in the chart above, notably serious fatigue, joint pain, and sexual symptoms (see details below).
A specific genetic basis for hemochromatosis (HFE) was first identified in 1996, but doctors had long known that the condition ran in families. For example, Ernest hemingway was diagnosed with HH in 1961 and it very likely contributed to his ill health and eventual suicide. His siblings Ursula and Leicester Hemingway are also likely to have suffered from HH (both of them committed suicide).
Despite being such a potentially harmful condition, for the last 30 years HH has been presented as one of the more straightforward genetic medical conditions. The story went like this: iron slowly accumulates in the body and symptoms appear only when iron levels become high. Health can be restored simply by removing the excess iron through phlebotomy (venesection in the “British” English nations).
This was a reassuring narrative, and for some patients it was broadly true. When doctors diagnosed HH in men and women who already had very high iron, enlarged livers, deep fatigue, skin changes, or joint pain, these patients were treated with frequent blood draws. These reduced iron levels and many patients improved dramatically. It was natural to conclude that iron overload caused the symptoms and that removing iron cured them. That model shaped public and clinical understanding for decades. But as research has expanded, the picture has changed in important ways.
The HFE Gene
Identifying a specific genetic cause for HH was a big step forward. Just as the development of simple blood tests in the 1970s had enabled accurate tracking of iron levels by measuring serum ferritin and transferrin saturation, the discovery of the HFE gene in 1996 made it possible to start tracking the condition across generations and discovering who might be susceptible to iron overload caused by HFE mutations.
Early genetic studies found more people than expected had HFE mutations, but the percentage of these people who developed iron overload was low (referred to as low penetrance). Unfortunately, this led many doctors to think of iron overload as a rare disease. This led to lower rates of diagnosis, which made it seem rarer. And because drawing blood can reduce a patient's iron to normal levels, and keep it there, HH was not thought of as a serious condition that impacted quality of life.
Modern research, however, has revealed that HH doesn’t always follow such a tidy script. We now know that organ damage can begin before the ferritin tests used do track iron levels are only an indirect reflection of what is happening inside the liver, pancreas, heart, and joints. It turns out that iron can accumulate in tissues long before blood markers look alarming, which means symptoms may affect the patient's health and quality of life earlier than the old model implied.
Another major shift in our understanding of HH is that some people with the classic genotype, C282Y homozygotes, never develop high ferritin at all, yet they still experience symptoms such as fatigue, joint pain, abdominal discomfort, or cognitive fog. This doesn’t mean their symptoms are unrelated or imagined; it simply means ferritin is not the whole story. Scientists are learning that the relationship between genotype, iron indices, and symptoms is more complex than once believed.
Updating HH Awareness and Care
The chart at the top of the article shows a "Top 19" of symptoms and issues reported by patients and/or doctors in a large 2025 study: Quality of life in hereditary haemochromatosis. Suffering from just a couple of those problems can make life miserable, but I've spoken to numerous people who have had to deal with 10 or more, including my wife. Fortunately, she is under the care of one of the authors of this study, which is well-worth reading. The goal was to understand:
"the full spectrum of symptoms and life impact of haemochromatosis as it presents to 21st century clinicians. This is a key starting point in establishing how much of the disease burden is purely related to the extent of iron overload and, ultimately, what improvement in QoL can be expected from a treatment (venesection) that was initially introduced into clinical practice primarily to improve prognosis."
Other research has revealed that some HH patients, like my wife, still experience problems even when their ferritin is successfully maintained at a normal level. HH-related joint damage, in particular, can be stubborn and sometimes irreversible. Impacts on cognitive ability are also being reported. Many people feel better after treatment but not fully “cured,” which contrasts with the optimism of earlier decades.
This evolution in understanding matters because older assumptions still circulate widely. Many people are told that if their ferritin is normal, HH cannot be causing their symptoms. Others are reassured that treatment will fix everything, only to find that some symptoms linger.
Updating awareness among clinicians and other medical professionals is needed. People need to recognise that HH can be subtle, that ferritin is only one piece of the puzzle, and that early detection should not depend on waiting for ferritin to rise. Hereditary hemochromatosis remains a condition with good outcomes when identified early. Phlebotomy may still prevent the most serious complications. But the modern view of HH acknowledges that symptoms can appear before ferritin climbs, that some people never develop high ferritin at all, and that certain problems, especially joint issues, may persist even with good iron control.
Sharing knowledge and understanding of these nuances can encourage people to seek appropriate care, advocate for themselves, and avoid being dismissed simply because their ferritin falls within a normal range.
A Note on HH and Sexual Issues
- Reduced libido (sex drive)
- Erectile dysfunction or difficulty maintaining erections
- Infertility or reduced fertility
- Testicular shrinkage
- Fatigue-related loss of sexual interest
- Low testosterone levels
- Loss of libido
- Menstrual irregularities or early menopause
- Infertility
- Painful intercourse related to hormonal changes
- Worsening fatigue that affects intimacy
References and Sources
Cundy T et al. Hypogonadism and Sexual Dysfunction in Hemochromatosis (1989).
NHS Genomics Education Programme: Hereditary haemochromatosis – Knowledge Hub.
- Canadian Hemochromatosis Society
- Facebook Hemochromatosis Page
- Haemochromatosis Australia
- Haemochromatosis UK
- Irish Haemochromatosis Association
- Iron Disorders Institute US
Comments
Post a Comment